Patheon is a global provider of development and commercial manufacturing services for solid and sterile prescription drugs, offering a wide variety of services and products. SEE AND Read More »

Want to learn more?

Patheon Overview Brochure

Excipient Compatibility Testing

At Patheon, we'll put the experience of thousands of projects to work when helping you to achieve the ideal dose form for your new drug product. A key component of this effort will be thorough but focused excipient compatibility testing program.

Excipient compatibility testing technologies

  • UPLC, HPLCs with UV, RI, PDA, electrochemical, conductivity, MS, and fluorescence detectors and GCs with FID, TCD, and MS detectors
  • ICP/AA
  • TGA and DSC
  • IR, UV, and NIR spectroscopy
  • ICH capable stability

Through Patheon, you'll have access to top scientists who have the expertise to understand your molecule and foresee the long-term impact of excipients on your formulation as your product progresses through the entire development cycle. They will use their experience to structure a prioritized testing program that maximizes efficiency and cost savings while giving you rock-solid results to build a successful product.

Case Study: Stability Through Excipient Compatibility Testing

The Challenge A customer came to Patheon with a new molecule that’s chemical structure indicated potential for oxidative degradation and hydrolysis. Their goal was to develop a solid oral dosage form that overcame these stability issues. 

The Solution To determine the level of degradation caused by specific excipients, Patheon conducted binary testing of dry and wet mixtures of API and multiple excipients. By employing accelerated conditions, this method of excipient compatibility testing allowed us to evaluate potency and impurities over a 1-3 month period.

The Outcome Patheon identified excipients not prone to degradation and incorporated antioxidants to further prevent degradation. With this data, we were able to focus efforts on a formulation with maximum stability.

Ask The Experts

Anil Kane, Ph.D., MBA

Anil Kane, Ph.D., MBA
Dr. Kane has more than 25 years of experience in the science and business of taking molecules throug
Read More »

Robert A. Lipper, Ph.D.

Robert A. Lipper, Ph.D.
Having ushered multiple products to market though the entire development process, Dr. Lipper is an e
Read More »

Joseph A. Fix, MBA, Ph.D.

Joseph A. Fix, MBA, Ph.D.
With 30 years of experience converting discoveries into businesses, Dr. Fix holds 24 patents, includ
Read More »

K. George Mooney, Ph.D.

K. George Mooney, Ph.D.
Dr. Mooney has 35 years’ experience in pharmaceutical sciences and exploratory drug development. He
Read More »

Larry Gatlin, Ph.D.

Larry Gatlin, Ph.D.
Dr. Gatlin is an industry veteran with more than 36 years of scientific and leadership experience. H
Read More »

Lynn Van Campen, Ph.D.

Lynn Van Campen, Ph.D.
With more than 30 years of drug development experience, Dr. Van Campen is an expert in the establish
Read More »

Mark A. Staples, Ph.D.

Mark A. Staples, Ph.D.
Having worked 32 years with all early to mid-stage companies, Dr. Staples is an expert at the early
Read More »

Leah Appel, Ph.D.

Leah Appel, Ph.D.
Dr. Appel has over 20 years’ experience in the pharmaceutical industry developing drug delivery tech
Read More »

View All »

Knowledge Library


Please fill the below form to access requested content

First Name

Last Name

Company

Title

Email

Phone

Address Line 1

Address Line 2

City

Zip/ Postal Code

Country

Submit